Drugmaker
- Lender group advised by law firm Gibson Dunn & Crutcher has been in discussions with the co. about how it can deal with the $200 million payment and possibly restructure its obligations
- Mallinckrodt hasn’t made a decision and could try to negotiate the settlement payment to avoid filing for bankruptcy
- Mallinckrodt spokesman declined to comment to the Wall Street ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.